Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,001 | -17,656 | -8,185 | -17,434 | -13,483 |
| Accounts receivable | 358 | 358 | 358 | N/A | N/A |
| Accounts payable and accrued liabilities | 104 | 1,240 | 1,124 | 2,238 | 2,195 |
| Other Working Capital | 12 | 165 | -967 | -193 | 3,360 |
| Other Operating Activity | 8,447 | 3,691 | 902 | 4,549 | 2,481 |
| Operating Cash Flow | $-20,080 | $-12,202 | $-6,768 | $-10,840 | $-5,447 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 18,433 | 12,433 |
| Common Stock Issued | 658 | 416 | 67 | N/A | N/A |
| Other Financing Activity | -1,269 | -1,269 | -1,269 | 68,656 | -129 |
| Financing Cash Flow | $-611 | $-853 | $-1,202 | $87,089 | $12,304 |
| Exchange Rate Effect | 656 | -114 | -6 | 3 | N/A |
| Beginning Cash Position | 83,602 | 83,602 | 83,602 | 7,350 | 7,350 |
| End Cash Position | 63,567 | 70,433 | 75,626 | 83,602 | 14,207 |
| Net Cash Flow | $-20,035 | $-13,169 | $-7,976 | $76,252 | $6,857 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,080 | -12,202 | -6,768 | -10,840 | -5,447 |
| Free Cash Flow | -20,080 | -12,202 | -6,768 | -10,840 | -5,447 |